𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiation therapy oncology group phase I–II study on fast neutron teletherapy for carcinoma of the bladder

✍ Scribed by George E. Laramore; Roger B. Davis; David H. Hussey; Thomas W. Griffin; Moshe H. Maor; Frank R. Hendrickson; Lawrence W. Davis; Eloise Dupre

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
783 KB
Volume
54
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I pilot study on fast neutron tele
Phase I pilot study on fast neutron teletherapy for advanced carcinomas of the head and neck region: Final report on local control rate and survival
✍ George E. Laramore; Thomas W. Griffin; Donald W. Tesh; Howard H. Wong; Robert G. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 811 KB

A final report is presented on the local control rate and length of survival for 100 patients with advanced squamous cell carcinomas of the head and neck region who received fast neutron teletherapy at the University of Washington during the period 1973 through 1977. Sixty-two patients were treated

A Phase I/II study of external beam radi
A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) : Final report
✍ Laurie E. Gaspar; Kathryn Winter; Walter I. Kocha; Lawrence R. Coia; Arnold Hers 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Background: A multiinstitutional, prospective study of the radiation therapy oncology group (rtog) was designed to determine the feasibility and toxicity of chemotherapy, external beam radiation, and esophageal brachytherapy (eb) in a potentially curable group of patients with adenocarcinoma or

Twice-daily fractionation of external ir
Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the radiation therapy oncology group 88—05
✍ Ritsuko Komaki; Thomas F. Pajak; Victor A. Marcial; Marvin Rotman; Perry W. Grig 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

1.9% at 1 year, and 6.3% at 2 and 3 years. Of 80 patients evaluated for response, 80% had complete disappearance of disease. Comparisons with historical rates of late toxicity with standard fractionation (STD) revealed similar results in spite of higher total doses with HFX. Comparisons between hist

Final report of a phase I/II trial of hy
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02
✍ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho

Interferon-α and chemohormonal therapy f
Interferon-α and chemohormonal therapy for patients with advanced melanoma : Final results of a Phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program
✍ James J. Stark; Robert O. Dillman; Richard Schulof; Michael C. Wiemann; Neil M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Background: The treatment of metastatic melanoma remains unsatisfactory despite encouraging results with biotherapy and combination chemotherapy. combining these two modalities may improve outcomes for such patients. ## Methods: Patients who were eligible for this study had metastatic melanoma